SCO-240 is an investigational, orally active, and selective somatostatin receptor subtype 5 (SSTR5) antagonist developed as a potential first-in-class treatment for growth hormone (GH) disorders.
For research use only. We do not sell to patients.
| Name | SCO-240 |
|---|---|
| Iupac Chemical Name | 6-(1-((2-cyclopropyl-5-ethoxy-4'-fluoro-[1,1'-biphenyl]-4-yl)methyl)piperidin-4-yl)-5-oxo-2-propyl-5,6,7,8-tetrahydro-1,6-naphthyridine-3-carboxylic acid |
| Synonyms | SCO-240; SCO240; SCO 240 |
| Molecular Formula | C35H40FN3O4 |
| Molecular Weight | 585.7 |
| Smile | O=C(C1=CC2=C(N=C1CCC)CCN(C3CCN(CC4=C(OCC)C=C(C5=CC=C(F)C=C5)C(C6CC6)=C4)CC3)C2=O)O |
| InChiKey | XOLOFGWOMQDGPZ-UHFFFAOYSA-N |
| InChi | InChI=1S/C35H40FN3O4/c1-3-5-31-30(35(41)42)19-29-32(37-31)14-17-39(34(29)40)26-12-15-38(16-13-26)21-24-18-27(22-6-7-22)28(20-33(24)43-4-2)23-8-10-25(36)11-9-23/h8-11,18-20,22,26H,3-7,12-17,21H2,1-2H3,(H,41,42) |
| CAS Number | 1695564-98-7 |
| Related CAS | 1695564-98-7 |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | ≧98.0% |
| Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
| Handling | Refer to MSDS |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| HS Code | 2934200090 |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |